首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1643894

全球無袖血壓監測設備市場 - 2025-2033

Global Cuffless Blood Pressure Monitoring Devices Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 246 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球無袖血壓監測設備市場規模達到6.8117億美元，預計2033年將達到17.315億美元，2025-2033年預測期間複合年成長率為10.7%。

無袖血壓計是具有多種用途的多種設備，但它們面臨特定的準確性問題，使得既定的驗證協議不夠充分。驗證應解決個人袖帶校準、測量穩定性、血壓變化追蹤和機器學習實施的問題。也可以考慮進行臨床現場調查來解決無袖血壓讀數的臨床實施問題。

市場動態：

驅動程式和限制

不斷進步的技術

感測器技術、人工智慧和機器學習的不斷進步正在推動準確、非侵入性無袖血壓計的開發。隨著物聯網技術的融合，遠端監控和遠距醫療應用進一步增強。小型化和多功能將使這些設備能夠嵌入智慧手錶和健身追蹤器等穿戴式產品中。這些發展使用戶對設備更加舒適並提高依從性，將他們引入慢性病管理和預防性醫療保健的日常工作中，從而導致市場成長。

例如，2024 年 11 月，CART BP 是世界上第一款專為連續血壓監測而設計的無袖帶環形設備，由韓國健康科技新創公司 Sky Labs 申請專利。與普通腕式智慧手錶不同，CART BP 透過光電體積描記法 (PPG) 提供更穩定的訊號，從而準確讀取流經手指的血流量。考慮到手腕尺寸的差異和感測器的機械未對準，手腕分佈式設備通常精度較差。

因此，這項創新在市場上樹立了新的基準，推動了對更可靠和方便用戶使用的監控解決方案的需求，這是幫助市場在預測期內成長的進步因素之一。

監管挑戰

全球無袖血壓監測設備市場受到監管挑戰的阻礙。醫療器材的核准流程因地區而異，為製造商創造了一個複雜的環境。缺乏統一的全球標準可能會導致產品開發的延遲、成本的增加以及新感測器的上市時間。監管政策的變化或不一致也會擾亂市場，使製造商難以維持一致的產品供應。因此，無袖血壓監測設備的推出減緩了整個產業的成長。

Omron
CardiacSense
Valencell, Inc
Aktiia SA
Equate Health
Healthstats International Pte. Ltd.
Corsano Health
SOMNOmedics AG
LiveMetric
Similar data will be provided for each market player.
索姆諾醫療有限公司
- 管道產品說明
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估算與預測
安德醫療
華為終端有限公司
將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄

Product Code: MD9058

The global cuffless blood pressure monitoring devices market reached US$ 681.17 million in 2024 and is expected to reach US$ 1731.5 million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033.

Cuffless blood pressure monitors are a diverse group of devices with various uses, but they face specific accuracy issues, making established validation protocols inadequate. Validation should address individual cuff calibration, measurement stability, BP change tracking, and machine learning implementation. Clinical field investigations may also be considered to address clinical implementation issues of cuffless BP readings.

Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

The ongoing advancements in sensor technology, artificial intelligence, and machine learning are leading to the development of accurate, non-invasive cuffless blood pressure monitors. With the integration of IoT technologies, remote monitoring and telemedicine applications are further enhanced. Miniaturization and multi-functionality will enable these devices to be embedded in wearable products such as smartwatches and fitness trackers. These developments make users more comfortable with the device and increase compliance, introducing them into the daily routine in chronic disease management and preventive health care and subsequently causing market growth.

For instance, in November 2024, CART BP is the first-ever cuffless ring-shaped device in the world designed for continuous blood pressure monitoring, patented by a health tech startup in South Korea, Sky Labs. Unlike ordinary wrist-based smart watches, CART BP provides more stable signals from photoplethysmography (PPG) to offer an accurate reading of blood flow through the finger. Wrist-distributed devices typically suffer from poor accuracy, considering differences in wrist sizes and mechanical misalignment of sensors.

Hence, this innovation sets a new benchmark in the market, driving demand for more reliable and user-friendly monitoring solutions which is one of the factor of advancements that helps the market to grow during the forecast period.

Regulatory Challenges

The global cuffless blood pressure monitoring devices market is hindered by regulatory challenges. The approval process for medical devices varies across regions, creating a complex landscape for manufacturers to navigate. This lack of uniform global standards can lead to delays in product development, increased costs, and time-to-market for new sensors. Changes or inconsistencies in regulatory policies can also disrupt the market, making it difficult for manufacturers to maintain consistent product offerings. As a result, the introduction of Cuffless Blood Pressure Monitoring Devices slows overall industry growth.

Segment Analysis

The global cuffless blood pressure monitoring devices market is segmented based on product type, technology, application, end user and region.

Product Type:

Wrist-based segment is expected to dominate the Cuffless Blood Pressure Monitoring Devices market share

The wrist-based segment holds a major portion of the cuffless blood pressure monitoring devices market share and is expected to continue to hold a significant portion of the cuffless blood pressure monitoring devices market share during the forecast period.

Cuffless blood pressure monitoring is one domain, in which wrist-based devices find their highest contribution in the global marketing space, making themselves all so convenient and portable that they can be integrated with wearable technologies. These devices also possess the advantage of neither storage nor continuous blood pressure monitoring, making them quite appealing to medical and consumer needs. The evolution that smartwatches have made from newly introduced fitness trackers with blood pressure sensors can act as factors that drive the advancement powered by the various improvements made in optical and piezoelectric sensing technologies. The other driving factors in the market would be the product launches, increasing demand for multipurpose wearables, unifying health monitoring with lifestyle features and other various factors.

For instance, in August 2023, Corsano Health announced that it has successfully integrated cuffless blood pressure measurements into its new generation smart bracelet. cardiowatch 287-2 is a wireless and remote patient monitoring solution that collects continuous physiological data from the home and health facility, including heart rate, heart rate variability (R-R interval), respiration rate, activity, sleep, ECG, SpO2, body temperature, and blood pressure.

End User:-

Hospitals segment is the fastest-growing segment in Cuffless Blood Pressure Monitoring Devices market share

The hospitals segment is the fastest-growing segment in the cuffless blood pressure monitoring devices market share and is expected to hold the market share over the forecast period.

Hospitals are sure catalyzers for the growth of the global cuffless blood pressure monitoring device markets, making available possibilities for continuous, non-invasive blood pressure monitoring. Such devices further enhance patient comfort during long-term or post-surgical recovery because they provide automated blood pressure recording and data capture on an on-going basis. Data transmission in real-time allows the identification of blood pressure deviations earlier enough to permit intervention by a healthcare provider. Incorporating cuffless devices into EHR systems boosts workflow efficiency and improves personalized patient care.

As more hospitals adopt telemedicine solutions, cuffless blood pressure monitors will be essential for remote patient monitoring programs to have care continuity and decrease readmission numbers. The segment is consequently critical for clinically competent and technologically advanced solutions.

Geographical Analysis

North America is expected to hold a significant position in the Cuffless Blood Pressure Monitoring Devices market share

North America holds a substantial position in the cuffless blood pressure monitoring devices market and is expected to hold most of the market share due to product launches, FDA clearance, advanced healthcare infrastructure and high healthcare expenditure. The rising prevalence of hypertension and cardiovascular diseases, coupled with an aging population, drives demand for innovative solutions. Technological advancements in wearable devices, telemedicine adoption, and home healthcare are key drivers. Strong regulatory frameworks, such as FDA approvals for cuffless devices, and growing consumer awareness about preventive health and wellness fuel market expansion in North America.

For instance, in January 2024, Nanowear is announced to be a front-runner in remote diagnostics for bringing health care home when it announced that its "nanotechnology-enabled wearable and software platform - SimpleSense has received FDA 510(k) clearance for a novel AI-enabled Software-as-a-MedicalDevice (SaMD). As the first non-invasive, cuffless continuous blood pressure monitor and diagnostics, SimpleSense BP is transforming a clinical diagnostic tool in the diagnostic management of hypertension and adds to the cardiopulmonary diagnostics previously cleared for the wearable platform.

Moreover, according to National Center for Health Statistics, in U.S Hypertension prevalence increases with age, with 23.4% in adults aged 18-39, 52.5% for 40-59, and 71.6% for 60 and older. Both men and women show a similar pattern, with higher prevalence in men aged 18-39 (30.0% compared to 16.4%) and 55.9% for 40-59, but not significantly different between men and women aged 60 and older.

Europe is growing at the fastest pace in the Cuffless Blood Pressure Monitoring Devices market

Europe holds the fastest pace in the cuffless blood pressure monitoring devices market and is expected to hold most of the market share due to growing focus on preventive healthcare and chronic disease management. The aging population and rising hypertension incidence drive demand for user-friendly monitoring solutions. Government initiatives, stringent regulatory standards, and collaborations between medical device companies and academic institutions contribute to growth. The integration of these devices into hospital systems and consumer wearables accelerates adoption across the region.

For instance, National Health Service, High blood pressure or hypertension is common among adults across the UK, at about one in three. In England, 31% of men have this condition, compared to 26% of women and up to six million across the UK, as described by Blood Pressure UK.

Hence, the high prevalence of hypertension among adults in the UK further demonstrates the importance of convening and accessible blood pressure monitoring technologies. Cuffless blood pressure monitoring devices facilitate continuous, non-invasive tracking of blood pressure for the convenience of users in self-managing their health. This development will contribute to market growth in line with the increasing emphasis by the UK on preventive healthcare and awareness campaigns for hypertension.

Competitive Landscape

The major global players in the cuffless blood pressure monitoring devices market include Biobeat Technologies, Omron, CardiacSense, Valencell, Inc, Aktiia SA, Equate Health, Healthstats International Pte. Ltd., Corsano Health, SOMNOmedics AG, LiveMetric and among others.

Key Developments

In November 2024, Movano Health Inc. has undergone testing its novel blood pressure wrist-worn instrument during its clinical trials which held at the University of California San Francisco on the 5th and 6th of November for hypoxia. The new device comes with added 12mm wave antennas which, in conjunction with Movano Health's custom IC, provide greater data collection versatility with reduced placement effects, along with a thinner form factor, making it easier to wear with comfort.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global cuffless blood pressure monitoring devices market report delivers a detailed analysis with 68+ key tables, more than 80 visually impactful figures, and 246 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Wrist-based*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Finger-based Monitors
6.4. Armband-based Monitors

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Pulse Transit Time (PTT) Technology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Optical Technology
7.4. Volume Clamp Technology
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Hypertension Management*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hypotension Management
8.4. Cardiovascular Risk Assessment
8.5. Remote Patient Monitoring

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Home Care Settings
9.4. Clinics
9.5. Diagnostic Centers

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Biobeat Technologies*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Omron
12.3. CardiacSense
12.4. Valencell, Inc
12.5. Aktiia SA
12.6. Equate Health
12.7. Healthstats International Pte. Ltd.
12.8. Corsano Health
12.9. SOMNOmedics AG
12.10. LiveMetric
Similar data will be provided for each market player.

Emerging Market Players

12.11. SOMNOmedics GmbH*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. A&D Medical
12.13. Huawei Device Co., Ltd.
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE